pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health
viewlistcards
Phase 3
influenza (trivalent) vaccine
Seasonal Influenza
$NVAXNOVAVAX INC
0 catalysts
Phase 2
influenza [Strain H5] vaccine
Pandemic Influenza
$SNYSanofi
0 catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent) vaccine
Flublok Quadrivalent
Influenza A Virus, H1N1 Subtype Infections
Sanofi Pasteur Inc
0 catalysts
← prev
page 220 of 271
next →
131
Pain89
Neurology1
Marketed
influenza [strains A/H1N1 + A/H3N2 + B/Victoria + B/Yamagata] (quadrivalent, split virion) vaccine
Flulaval Quadrivalent
Influenza A Virus, H1N1 Subtype Infections
GlaxoSmithKline Consumer Healthcare LP
0 catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B] (split virion) vaccine
Fluzone
Influenza A Virus, H1N1 Subtype Infections
Sanofi Pasteur Inc
0 catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B] (trivalent) vaccine
Flucelvax
Influenza A Virus, H1N1 Subtype Infections
Seqirus Ltd
0 catalysts
Marketed
influenza [strains A/H1N1 + A/H3N2 + B] (trivalent, split virion) vaccine
Afluria
Influenza A Virus, H1N1 Subtype Infections
Seqirus Ltd
0 catalysts
Preclinical
influenza [strains A/H1N1] vaccine
Influenza A Virus, H1N1 Subtype Infections
CEL-SCI Corp
0 catalysts
Marketed
influenza [types A and B] (quadrivalent) vaccine
Flucelvax Quadrivalent
Influenza A Virus, H1N1 Subtype Infections
Seqirus Ltd
0 catalysts
Phase 2
influenza vaccine 2
Unspecified Influenza Virus Infections
$JNJJOHNSON & JOHNSON
0 catalysts
Phase 2
inlexisertib
Gastrointestinal Stromal Tumor (GIST)
Deciphera Pharmaceuticals Inc
0 catalysts
Phase 2
inobrodib
Refractory Multiple Myeloma
CellCentric Ltd
0 catalysts
Preclinical
inotodiol
Duchenne Muscular Dystrophy
Animuscure Co Ltd
0 catalysts
Marketed
inotuzumab ozogamicin
Besponsa (inotuzumab ozogamicin)
B-Cell Acute Lymphocytic Leukemia (B-Cell Acute Lymphoblastic Leukaemia)
$PFEPFIZER INC
0 catalysts
pre_registration
insulin aspart
Kirsty (insulin aspart)
Type 1 Diabetes (Juvenile Diabetes)
Insulin receptor
Gan & Lee Pharmaceuticals Co Ltd
0 catalysts
pre_registration
insulin aspart biosimilar
Type 2 Diabetes
Tonghua Dongbao Pharmaceutical Co Ltd
0 catalysts
Preclinical
insulin biosimilar
Diabetes
Lamark Biotech Pvt Ltd
0 catalysts
Marketed
insulin degludec LA
Tresiba (insulin degludec)
Type 1 Diabetes (Juvenile Diabetes)
Novo Nordisk Inc
0 catalysts
Marketed
insulin detemir LA
Levemir (insulin detemir)
Type 1 Diabetes (Juvenile Diabetes)
Novo Nordisk Inc
0 catalysts
pre_registration
insulin efsitora alfa
Type 2 Diabetes
Eli Lilly and Co
0 catalysts
pre_registration
insulin glargine
Novolin R (insulin glargine)
Type 1 Diabetes (Juvenile Diabetes)
Insulin receptor
Lannett Co Inc
0 catalysts
pre_registration
insulin glargine LA
Lantus (insulin glargine)
Type 1 Diabetes (Juvenile Diabetes)
Insulin receptor
Gan & Lee Pharmaceuticals Co Ltd
0 catalysts
Marketed
insulin glulisine
Apidra (insulin glulisine)
Type 1 Diabetes (Juvenile Diabetes)
Sanofi-Aventis US LLC
0 catalysts
Phase 3
insulin human (recombinant)
insulin human
Malabsorption Syndrome
Insulin receptor
Elgan Pharma Ltd
0 catalysts
Marketed
insulin isophane
Humulin N (insulin isophane [INN])
Type 1 Diabetes (Juvenile Diabetes)
Lilly USA LLC
0 catalysts
pre_registration
insulin lispro
Type 1 Diabetes (Juvenile Diabetes)
Insulin receptor
Gan & Lee Pharmaceuticals Co Ltd
0 catalysts
Phase 1
insulin lispro biosimilar
Admelog Solostar
Diabetes
Tonghua Dongbao Pharmaceutical Co Ltd
0 catalysts
Marketed
interferon alfa-2b
Intron A (interferon alfa-2b)
Genital Warts (Condylomata Acuminata)
Schering-Plough Corp (Inactive)
0 catalysts
Phase 2
interferon alpha
Warts
Interferon alpha/beta receptor
$AIMDAinos, Inc.
0 catalysts
Marketed
interferon beta-1a
Rebif (interferon beta-1a)
Relapsing Remitting Multiple Sclerosis (RRMS)
EMD Serono Inc
0 catalysts